Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.535 USD | +3.62% |
|
0.00% | -2.78% |
Jul. 04 | Bpifrance eyes investment in Sanofi's consumer health business | RE |
Jul. 02 | Fosun International Unit to Sell Restaurant, Tourism Company | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company sustains low margins.
- One of the major weak points of the company is its financial situation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.78% | 4.41B | - | ||
+3.96% | 125B | A- | ||
+7.28% | 99.94B | C+ | ||
+21.90% | 73.37B | - | B+ | |
+33.06% | 70.56B | C | ||
+24.92% | 47.98B | C+ | ||
+12.96% | 42.62B | A- | ||
+26.48% | 38.24B | A- | ||
+12.13% | 26.96B | B | ||
+9.50% | 25.38B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 656 Stock
- FOSUF Stock
- Ratings Fosun International Limited